Prostatype Genomics AB (publ) (PGABF)
OTCMKTS · Delayed Price · Currency is USD
0.0850
-0.2734 (-76.28%)
At close: Jan 7, 2026
Prostatype Genomics AB Market Cap
Prostatype Genomics AB has a market cap or net worth of $10.87 million as of February 12, 2026. Its market cap has increased by 86.40% in one year.
Market Cap
10.87M
Enterprise Value
9.42M
Revenue
75.19K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since November 3, 2020, Prostatype Genomics AB's market cap has increased from 10.45M to 10.87M, an increase of 3.97%. That is a compound annual growth rate of 0.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 10.87M | 462.42% |
| Dec 30, 2025 | 1.93M | -71.33% |
| Dec 30, 2024 | 6.74M | 498.82% |
| Dec 29, 2023 | 1.13M | -75.80% |
| Dec 30, 2022 | 4.65M | -68.82% |
| Dec 30, 2021 | 14.91M | -35.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coastal Capital Acquisition | 8.34M |
| Carver Bancorp | 8.32M |
| Tel-Instrument Electronics | 8.30M |
| BMP AI Technologies | 8.29M |
| Union Financial | 8.27M |
| ProtoSource | 8.26M |
| Biotricity | 8.22M |
| Hi-Great Group Holding Company | 8.21M |